“…RGM have been described in pulmonary infections, keratitis, endophthalmitis, suppurative arthritis, osteomyelitis, endocarditis, meningitis, peritonitis, chronic urinary tract infection, otitis media related to tympanostomy tube insertion and catheter-associated bacteremia. The members of the Mycobacterium fortuitum complex, M. chelonae and M. abscessus are the species most frequently associated with human infections; the rest of species are minority and occasionally reported (2,3,6,13,14). Evaluation of INNO-LiPA Mycobacteria Identification of new species of RGM producing nosocomial infections and serious infections in oncological and immunocompromised patients has been possible thanks to the development of modern microbiological diagnosis systems and genetic methods, such as the sequencing of bacterial 16S rRNA region or the restriction enzyme pattern analysis of the hsp65 gene (PRA), which encodes for the 65-kDa heat shock protein (1,8,10).…”